Coronavirus (COVID-19): Important Information From Scripps Learn more

Active Studies

COVID-19 update:

In response to the COVID pandemic, Scripps Health has temporarily suspended enrollment for all clinical trials. Exceptions will exist for trials with curative intent, life-saving treatment or when no standard of care exists. For questions, please call Scripps Office for the Protection of Research Subjects at 858-678-6402.

Showing 1-10 results of 39 total

Cancer|Gastroenterology

New investigational drug for untreated metastatic pancreatic cancer

This trial is currently enrolling

This research study is investigating the safety of an experimental drug called SBP-101. The main goal is to assess the safety of SBP-101 when given in...

Cancer|Gastroenterology

PROOF Trial: Investigational new drug for the treatment of bile duct cancer

This trial is currently enrolling

This study is comparing an investigational oral drug called infigratinib to the standard treatment for patients with cholangiocarcinoma.

Cancer|Urology

A Randomized Trial of Immunotherapy with or without Surgical Treatment

This trial is currently enrolling

This study will assess the safety and effectiveness of Pembrolizumab (KEYTRUDA) compared to surgical treatment (removal of bladder) alone in patients with...

Cancer|Urology

Combined Immunotherapy and Chemotherapy for Muscle-invasive Bladder Cancer

This trial is currently enrolling

This study will test the effectiveness of Pembrolizumab (KEYTRUDA) given before and after surgery for the treatment of muscle-invasive bladder cancer....

Cancer|Hepatology|Liver Diseases

Investigational Drug for Hepatocellular Carcinoma (HCC)/Liver Cancer

This trial is currently enrolling

ABX196 is an investigational immune therapy. For this study, it will be combined with an FDA approved dose of nivolumab. The purpose of this Phase I study is...

Cancer|Hepatology|Liver Diseases

Investigational drug treatment for advanced liver cancer.

This trial is currently enrolling

This study will test the safety and effectiveness of Pembrolizumab (KEYTRUDA®) in combination with Lenvatinib for the treatment of advanced liver cancer. The...

Cancer|Hepatology|Liver Diseases

Investigational drug study for advanced liver cancer

This trial is currently enrolling

This study will evaluate the safety and effectiveness of an investigational immunotherapy drug called atezolizumab, in combination with a chemotherapy drug...

Cancer

Short duration infusion for treatment of Follicular Lymphoma

This trial is currently enrolling

The purpose of this study is to test the safety and effectiveness of a short duration infusion (90 minute infusion) of obinutuzumab in patients who have...

Cancer|Lung Disorders

Investigational drug treatment for previously untreated metastatic NSCLC

This trial is currently enrolling

Investigational drug treatment for patients diagnosed with metastatic non-small cell lung cancer that has not been previously treated.

The purpose of...

Cancer|Lung Disorders

Investigational drug study for Treatment of Non-Small Cell Lung Cancer

This trial is currently enrolling

This study will test the safety of an experimental drug called atezolizumab given in combination with other chemotherapy drugs. Patients will receive 4...